Hologic (NSDQ:HOLX) announced today that it completed the placement the 1000th Panther automated molecular instrument system in a U.S. diagnostics laboratory.
The Panther system was unveiled at PathGroup in Nashville, Tenn. PathGroup is a large provider of anatomic, clinical and molecular pathology laboratory services with over 15,000 physician clients, hospitals and surgery centers across the country.
“We are pleased that Hologic has chosen PathGroup as the recipient of the 1,000th Panther molecular diagnostic testing system in the United States,” PathGroup executive VP & COO Michael Hanbury said in a news release. “This placement is representative of the multi-decade collaboration between our companies to advance awareness, diagnosis and treatment options in women’s health.”
The Panther system is designed with adaptable workflow options and a consolidated testing menu to combine women’s health, sexually transmitted infections and viral load testing, all of which can be done simultaneously, according to a news release. It also offers an expanded in-vitro diagnostics menu and open access to laboratory-developed tests.
Hologic’s Panther system, which was launched in Europe in 2010 and in the U.S. in 2012, now offers 16 FDA-cleared assays and 20 CE-marked tests for detecting more than 20 pathogens.
“Our laboratory partners are the unsung heroes of medicine,” Hologic diagnostic solutions division president Kevin Thornal said. “Every day they are working nonstop to supply vital information that drives effective patient care. It is truly an honor to support their mission with our large installed base of Panther systems and broad assay menu.”
